ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 66 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,750,000 | +114.0% | 1,032,715 | 0.0% | 0.20% | +92.3% |
| Q2 2017 | $2,220,000 | -31.8% | 1,032,715 | 0.0% | 0.10% | -32.5% |
| Q1 2017 | $3,253,000 | +21.2% | 1,032,715 | 0.0% | 0.15% | +0.7% |
| Q4 2016 | $2,685,000 | -57.8% | 1,032,715 | -36.8% | 0.15% | -58.5% |
| Q3 2016 | $6,359,000 | +65.9% | 1,634,608 | +14.7% | 0.37% | +27.2% |
| Q2 2016 | $3,834,000 | -12.7% | 1,425,439 | 0.0% | 0.29% | -15.0% |
| Q1 2016 | $4,390,000 | -20.0% | 1,425,439 | 0.0% | 0.34% | +11.8% |
| Q4 2015 | $5,488,000 | +8.6% | 1,425,439 | -14.0% | 0.30% | +25.5% |
| Q3 2015 | $5,053,000 | -44.2% | 1,656,644 | -22.4% | 0.24% | -39.7% |
| Q2 2015 | $9,056,000 | +9.8% | 2,135,739 | 0.0% | 0.40% | -1.2% |
| Q1 2015 | $8,244,000 | -42.5% | 2,135,739 | +0.3% | 0.41% | -51.5% |
| Q4 2014 | $14,325,000 | +60.8% | 2,128,539 | +31.2% | 0.84% | +26.3% |
| Q3 2014 | $8,908,000 | – | 1,622,654 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |